Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Illumina Inc
Illumina Inc
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Almac expands sequencing capabilities through llumina instrument
Almac has purchased and installed an llumina NovaSeq X Plus instrument in Northern Ireland, which is set to expand its next generation sequencing capabilities for BioPharma partners
Regulatory
CMA challenges major genetic sequencing merger
The CMA has provisionally concluded that Illumina’s acquisition of Pacific Biosciences of California would result in a ‘substantial lessening of competition’
Research & Development
IDT partners with Illumina for NGS library preparation
Leaders in NGS tools collaborate to deliver robust multiplexing capabilities and streamline target enrichment methods
Research & Development
Almac to collaborate with Illumina on next-generation sequencing-based companion diagnostic development
The partnership with Illumina will provide an additional platform for the delivery of complex assays, expanding the options available to Almac partners
Design & Build
BioMed Realty and Illumina announce new build-to-suit laboratory building in Cambridge, UK
New state-of-the-art building to be located in scientific research park and will serve as Illumina's new European headquarters
Research & Development
Merck Serono and Illumina enter collaboration for diagnostics in oncology
Will develop assays that detect and measure multiple genetic variants in a single tumour sample to support clinical trials
Research & Development
Scotland to be at forefront of gene-led healthcare in £15m project with Illumina
Scottish Genomes Partnership will include Universities of Edinburgh and Glasgow
Subscribe now